BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Circadin (Melatonin prolonged-release) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Circadin (Melatonin prolonged-release)\, 
 from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06489327-7540@assetmemo.bio
DTSTAMP:20261121T005857Z
DTSTART;VALUE=DATE:20261215
DTEND;VALUE=DATE:20261216
SUMMARY:Circadin (Melatonin prolonged-release): Phase na readout est. (NCT0
 6489327)
DESCRIPTION:Circadin (Melatonin prolonged-release)\, phase na.\nStudy: Comp
 aring Two Doses of Oral Melatonin as Premedication in Children Undergoing 
 Surgery\nEstimated primary completion: 15 December 2026. This is a Clinica
 lTrials.gov estimate\, not a confirmed readout date\, and it can move.\nDr
 ug page: https://assetmemo.bio/drug/melatonin-prolonged-release#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT06489327
URL:https://assetmemo.bio/drug/melatonin-prolonged-release#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07737665-7540@assetmemo.bio
DTSTAMP:20261121T005857Z
DTSTART;VALUE=DATE:20270401
DTEND;VALUE=DATE:20270402
SUMMARY:Circadin (Melatonin prolonged-release): Phase 4 readout est. (NCT07
 737665)
DESCRIPTION:Circadin (Melatonin prolonged-release)\, phase 4.\nStudy: Effic
 acy of Melatonin Treatment on Sleep Quality Improvement in Inflammatory Bo
 wel Disease Patients With Clinical Remission\nEstimated primary completion
 : 1 April 2027. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/melat
 onin-prolonged-release#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07737665
URL:https://assetmemo.bio/drug/melatonin-prolonged-release#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT03438526-7540@assetmemo.bio
DTSTAMP:20261121T005857Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Circadin (Melatonin prolonged-release): Phase 4 readout est. (NCT03
 438526)
DESCRIPTION:Circadin (Melatonin prolonged-release)\, phase 4.\nStudy: The B
 asel BOMP-AID Randomized Trial\nEstimated primary completion: December 202
 7. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, 
 and it can move.\nDrug page: https://assetmemo.bio/drug/melatonin-prolonge
 d-release#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT03438526
URL:https://assetmemo.bio/drug/melatonin-prolonged-release#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
